A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

Last updated: April 21, 2025
Sponsor: Weill Medical College of Cornell University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Mastectomy

Breast Reconstruction

Treatment

REVOLVE Advanced Adipose System

Standard Decantation technique

Viality

Clinical Study ID

NCT04891510
20-10022850
  • Ages > 18
  • Female

Study Summary

The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female;

  • Documented history of previous breast surgery (either complete or partialmastectomy);

  • Available harvest sites for fat grafting as documented by plastic surgeon;

  • BMI > 20;

  • Anticipated harvested fat volume > 50cc;

  • Competency and willingness to provide consent

Exclusion

Exclusion Criteria:

  • Suspected or known to be pregnant

Study Design

Total Participants: 135
Treatment Group(s): 4
Primary Treatment: REVOLVE Advanced Adipose System
Phase:
Study Start date:
May 19, 2021
Estimated Completion Date:
May 31, 2025

Connect with a study center

  • New York Presbyterian - Weill Cornell Medicine

    New York, New York 10021
    United States

    Active - Recruiting

+−

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.